• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

死于 SARS-CoV-2:罗马尼亚 COVID-19 多中心合并症研究。

Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.

机构信息

University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu Str., 020021, Bucharest, Romania.

National Institute of Diabetes, Nutrition and Metabolic Diseases "N. C. Paulescu", 5-7. Ion Movila Str, 030167, Bucharest, Romania.

出版信息

Sci Rep. 2020 Dec 10;10(1):21613. doi: 10.1038/s41598-020-78575-w.

DOI:10.1038/s41598-020-78575-w
PMID:33303885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7730445/
Abstract

Evidence regarding the relation between SARS-CoV-2 mortality and the underlying medical condition is scarce. We conducted an observational, retrospective study based on Romanian official data about location, age, gender and comorbidities for COVID-19 fatalities. Our findings indicate that males, hypertension, diabetes, obesity and chronic kidney disease were most frequent in the COVID-19 fatalities, that the burden of disease was low, and that the prognosis for 1-year survival probability was high in the sample. Evidence shows that age-dependent pairs of comorbidities could be a negative prognosis factor for the severity of disease for the SARS-CoV 2 infection.

摘要

关于 SARS-CoV-2 死亡率与基础疾病之间关系的证据很少。我们基于罗马尼亚关于 COVID-19 死亡病例的位置、年龄、性别和合并症的官方数据,进行了一项观察性、回顾性研究。我们的研究结果表明,男性、高血压、糖尿病、肥胖和慢性肾脏病在 COVID-19 死亡病例中最为常见,疾病负担较低,样本中 1 年生存率的预后较高。有证据表明,年龄相关的合并症对 SARS-CoV-2 感染的疾病严重程度可能是一个负面预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c7/7730445/2f3f3bad5809/41598_2020_78575_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c7/7730445/09ac8c3e1c96/41598_2020_78575_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c7/7730445/2f3f3bad5809/41598_2020_78575_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c7/7730445/09ac8c3e1c96/41598_2020_78575_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c7/7730445/2f3f3bad5809/41598_2020_78575_Fig2_HTML.jpg

相似文献

1
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.死于 SARS-CoV-2:罗马尼亚 COVID-19 多中心合并症研究。
Sci Rep. 2020 Dec 10;10(1):21613. doi: 10.1038/s41598-020-78575-w.
2
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
3
Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.尼日利亚拉各斯 COVID-19 患者合并与不合并高血压的发病率和死亡率结局:一项回顾性队列研究。
Glob Health Res Policy. 2021 Jul 29;6(1):26. doi: 10.1186/s41256-021-00210-6.
4
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
5
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease.伊朗 COVID-19 患者的临床表现:千面疾病。
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.
6
Adaptation of a Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data.俄罗斯人群对 SARS-CoV-2 的适应:无症状病程、合并症、死亡率和其他呼吸道病毒——对“恐惧与数据”的回应。
Int J Antimicrob Agents. 2020 Oct;56(4):106093. doi: 10.1016/j.ijantimicag.2020.106093. Epub 2020 Jul 10.
7
Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.心血管危险因素和心血管疾病对大邱市 COVID-19 住院患者结局的影响。
J Korean Med Sci. 2021 Jan 11;36(2):e15. doi: 10.3346/jkms.2021.36.e15.
8
Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.冠状病毒病(COVID-19):一项系统综述和荟萃分析,以评估各种合并症对严重事件的影响。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1017-1025. doi: 10.1016/j.dsx.2020.06.064. Epub 2020 Jul 2.
9
Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France.法国马赛市 COVID-19 疫情三个阶段期间一家医院内不同 SARS-CoV-2 变异株感染患者的临床结局。
Infect Genet Evol. 2021 Nov;95:105092. doi: 10.1016/j.meegid.2021.105092. Epub 2021 Sep 24.
10
Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico.高血压、糖尿病和肥胖症是墨西哥 COVID-19 患者死亡的主要危险因素。
Arch Med Res. 2021 May;52(4):443-449. doi: 10.1016/j.arcmed.2020.12.002. Epub 2020 Dec 16.

引用本文的文献

1
Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study.哥伦比亚新冠肺炎重症监护病房住院患者的高血糖、糖尿病和新发糖尿病:一项纵向队列研究的结果
J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):257-264. doi: 10.2478/jccm-2025-0026. eCollection 2025 Jul.
2
Comorbidities and Severe COVID-19 Outcomes: A Retrospective Analysis of Hospitalized Patients in Three Counties in Romania.合并症与重症 COVID-19 结局:罗马尼亚三个县住院患者的回顾性分析
Microorganisms. 2025 Mar 29;13(4):787. doi: 10.3390/microorganisms13040787.
3

本文引用的文献

1
COVID-19 - exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study.2019冠状病毒病——探究长期病症类型和共病程度对寿命损失年数的影响:一项建模研究
Wellcome Open Res. 2021 Mar 1;5:75. doi: 10.12688/wellcomeopenres.15849.3. eCollection 2020.
2
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study.COVID-19 患者 3894 例的常见心血管危险因素与住院死亡率:来自意大利多中心 CORIST 研究的生存分析和基于机器学习的发现。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913. doi: 10.1016/j.numecd.2020.07.031. Epub 2020 Jul 31.
3
Coping strategies, resilience and quality of life: reaction to the COVID-19 pandemic among Romanian physicians.
应对策略、韧性和生活质量:罗马尼亚医生对 COVID-19 大流行的反应。
Hum Resour Health. 2024 May 7;22(1):28. doi: 10.1186/s12960-024-00909-w.
4
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.COVID-19 中的新发糖尿病:一项范围综述
Diabetes Ther. 2024 Jan;15(1):33-60. doi: 10.1007/s13300-023-01465-7. Epub 2023 Sep 26.
5
The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases.一种针对心脏代谢疾病的新型综合征方法的重要性。
Curr Med Chem. 2024;31(18):2483-2485. doi: 10.2174/0929867331666230918114009.
6
Perceptions and Expectations of Academic Staff in Bucharest towards the COVID-19 Pandemic Impact on Dental Education.布加勒斯特高校教职人员对新冠疫情对牙科教育影响的认知和期望。
Int J Environ Res Public Health. 2023 Jan 18;20(3):1782. doi: 10.3390/ijerph20031782.
7
Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study.大流行最初几个月中,绝对高血糖与应激性高血糖比值对COVID-19住院患者预后的影响:一项回顾性研究
Diabetes Ther. 2023 Feb;14(2):335-346. doi: 10.1007/s13300-022-01347-4. Epub 2022 Dec 27.
8
Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly.COVID-19 大流行对肢端肥大症患者疾病控制状况和生活质量的影响。
Medicina (Kaunas). 2022 Nov 23;58(12):1711. doi: 10.3390/medicina58121711.
9
Does the Hyperglycemia Impact on COVID-19 Outcomes Depend upon the Presence of Diabetes?-An Observational Study.高血糖对2019冠状病毒病(COVID-19)预后的影响是否取决于糖尿病的存在?一项观察性研究。
Metabolites. 2022 Nov 15;12(11):1116. doi: 10.3390/metabo12111116.
10
Cross-sectional study for COVID-19-related mortality predictors in a Brazilian state-wide landscape: the role of demographic factors, symptoms and comorbidities.巴西全州范围内 COVID-19 相关死亡率预测因素的横断面研究:人口统计学因素、症状和合并症的作用。
BMJ Open. 2022 Oct 17;12(10):e056801. doi: 10.1136/bmjopen-2021-056801.
Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis.评估伊朗多发性硬化症患者 COVID-19 感染、住院和死亡的发生率。
Mult Scler Relat Disord. 2020 Nov;46:102472. doi: 10.1016/j.msard.2020.102472. Epub 2020 Aug 29.
4
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids.新冠病毒病的病程:来自意大利一个队列的数据及类固醇的潜在作用。
Microorganisms. 2020 Aug 31;8(9):1327. doi: 10.3390/microorganisms8091327.
5
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters.大流行中心非老年人群和非老年无基础疾病人群的 COVID-19 总体人群死亡率风险。
Environ Res. 2020 Sep;188:109890. doi: 10.1016/j.envres.2020.109890. Epub 2020 Jul 1.
6
Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy.意大利报告的 COVID-19 死亡人数与总死亡率上升的比较。
JAMA Intern Med. 2020 Sep 1;180(9):1250-1252. doi: 10.1001/jamainternmed.2020.2543.
7
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.COVID-19 合并糖尿病住院患者的表型特征和预后:CORONADO 研究。
Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29.
8
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.COVID-19 患者的性别差异:关注严重程度和死亡率。
Front Public Health. 2020 Apr 29;8:152. doi: 10.3389/fpubh.2020.00152. eCollection 2020.
9
Diabetes and COVID-19: evidence, current status and unanswered research questions.糖尿病与 COVID-19:证据、现状及待解决的研究问题。
Eur J Clin Nutr. 2020 Jun;74(6):864-870. doi: 10.1038/s41430-020-0652-1. Epub 2020 May 13.
10
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.